University of Cambridge > Talks.cam > Darwin College Sciences Group > How modifications to proteins lead to Parkinson's Disease

How modifications to proteins lead to Parkinson's Disease

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Sven Friedemann.

Parkinson’s disease is a neurodegenerative disease characterized by inclusions of a small intrinsically disordered protein (14 kDa), α‐synuclein (AS) in Lewy Bodies. Modifications to AS, such as point mutations (A30P, A53T , E46K), phosphorylation of Tyrosine 125 and Serine 129, N-terminal acetylation as well as C‐terminal truncations might affect functioning of the protein as well as its aggregation behaviour into amyloid fibrils. However, detailed mechanistic understanding of the molecular events that lead to the conversion of soluble protein into insoluble aggregates is currently lacking for AS. I will give a short introduction to neurodegenerative diseases in general and explain how my research aims to elucidate the mechanisms that operate in Parkinson’s Disease.

This talk is part of the Darwin College Sciences Group series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2020 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity